CANDICE BLACKWOOD: Open Payments
NPI 1306516893 · DECATUR, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$707 in 39 payments from 11 companies in 2025. Trend: 2023 $209 · 2024 $299 · 2025 $707
Food & beverage: $707
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 12 | $199 |
| Novo Nordisk Inc | 11 | $190 |
| Exact Sciences Corporation | 4 | $89 |
| ABBVIE INC. | 2 | $49 |
| Lilly USA, LLC | 3 | $48 |
| AstraZeneca Pharmaceuticals LP | 2 | $37 |
| Novartis Pharmaceuticals Corporation | 1 | $29 |
| GlaxoSmithKline, LLC. | 1 | $20 |
| Esperion Therapeutics, Inc. | 1 | $16 |
| Kowa Pharmaceuticals America, Inc. | 1 | $16 |
Products named: OTEZLA, Ozempic, The Cologuard Plus Collection Kit, Wegovy, Rybelsus, VRAYLAR, MOUNJARO, REPATHA.
Industry payments across AL — which companies pay providers there.
